Olaparib in the Therapy of Advanced Ovarian Cancer: First Real World Experiences in Safety and Efficacy From China

Journal of Ovarian Research - United Kingdom
doi 10.1186/s13048-019-0594-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Profile of Olaparib in the Treatment of Advanced Ovarian Cancer

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2016English

Real-World Efficacy and Safety of Eribulin in Advanced and Pretreated HER2-negative Breast Cancer in a Spanish Comprehensive Cancer Center

BMC pharmacology & toxicology
MedicinePharmacology
2019English

Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Efficacy and Safety of Chemotherapy in Older Versus Non-Older Patients With Advanced Gastric Cancer: A Real-World Data, Non-Inferiority Analysis

Journal of Geriatric Oncology
GerontologyGeriatricsOncology
2018English

Nimotuzumab in Advanced Cervical Cancer: Safety and Efficacy Profile

International Journal of Oncology Research
2019English

Real World Treatment Patterns of Patients With Ovarian Cancer Receiving First Line Chemotherapy in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pcn2 - Effectiveness and Safety of Pembrolizumab in Advanced or Metastatic Melanoma: Preliminary Results From Real World

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients With Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase‐R)

Oncologist
Cancer ResearchMedicineOncology
2019English

Metronomic Chemotherapy Enhances the Efficacy of Antivascular Therapy in Ovarian Cancer

Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy